Page last updated: 2024-09-05

sorafenib and Endometrial Hyperplasia

sorafenib has been researched along with Endometrial Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gao, ZH; Guo, XC; Ji, M; Li, L; Wang, QQ	1

Other Studies

1 other study(ies) available for sorafenib and Endometrial Hyperplasia

Article	Year
Treatment with metformin and sorafenib alleviates endometrial hyperplasia in polycystic ovary syndrome by promoting apoptosis via synergically regulating autophagy. Journal of cellular physiology, 2020, Volume: 235, Issue:2 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Drug Synergism; Endometrial Hyperplasia; Female; Metformin; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Sorafenib	2020

Article

Year

Treatment with metformin and sorafenib alleviates endometrial hyperplasia in polycystic ovary syndrome by promoting apoptosis via synergically regulating autophagy.

Journal of cellular physiology, 2020, Volume: 235, Issue:2

Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Drug Synergism; Endometrial Hyperplasia; Female; Metformin; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Sorafenib

2020